Lumos Diagnostics Holdings Limited (LDXHF)
OTCMKTS · Delayed Price · Currency is USD
0.0768
-0.0241 (-23.85%)
Oct 6, 2025, 11:29 AM EDT
LDXHF Market Cap
LDXHF has a market cap or net worth of $77.86 million as of October 6, 2025. Its market cap has increased by 515.50% in one year.
Market Cap
77.86M
Enterprise Value
82.93M
Revenue
12.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.08
Market Cap Chart
Since July 5, 2021, LDXHF's market cap has decreased from 148.12M to 77.86M, a decrease of -47.43%. That is a compound annual growth rate of -14.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 77.86M | 380.23% |
| Dec 31, 2024 | 16.21M | -32.31% |
| Dec 29, 2023 | 23.95M | 249.55% |
| Dec 30, 2022 | 6.85M | -93.71% |
| Dec 31, 2021 | 108.92M | -26.46% |
| Jul 5, 2021 | 148.12M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 798.20M |
| Elite Pharmaceuticals | 686.89M |
| Glass House Brands | 644.95M |
| Northwest Biotherapeutics | 382.92M |
| Nika Pharmaceuticals | 333.67M |
| CytoDyn | 326.79M |
| American Oncology Network | 281.53M |
| Silence Therapeutics | 236.17M |